Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 14;17(12):5296–5303. doi: 10.1080/21645515.2021.2002085

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 GlaxoSmithKline Biologicals SA. Published with license by Taylor & Francis Group, LLC.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — RZV vaccine efficacy estimates with associated annual wanings, public health impact in the German population and cost-effectiveness.

*A fixed cohort of a total of 1 M subjects at each age is assumed, of which 40% were assumed to be vaccinated with the first dose and 70% would receive a second dose of RZV. HZ: herpes zoster; K: thousands; M: million; PHN: postherpetic neuralgia; QALY: quality adjusted life-years, RZV: recombinant zoster vaccine; YOA: years of age.